{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:52:47Z","timestamp":1790650367728,"version":"4.1.0"},"reference-count":169,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI110335"],"award-info":[{"award-number":["AI110335"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1157210"],"award-info":[{"award-number":["OPP1157210"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2017.00171","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T00:13:56Z","timestamp":1508285636000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":146,"title":["Host-Directed Therapeutic Strategies for Tuberculosis"],"prefix":"10.3389","volume":"4","author":[{"given":"Afsal","family":"Kolloli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvakumar","family":"Subbian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,10,18]]},"reference":[{"key":"B1","volume-title":"Global Tuberculosis Report","year":"2016"},{"key":"B2","volume-title":"Tuberculosis Fact Sheet","year":"2017"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1128\/IAI.00443-12","article-title":"Innate immune gene polymorphisms in tuberculosis","volume":"80","author":"Azad","year":"2012","journal-title":"Infect Immun"},{"key":"B4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1056\/NEJMra1200894","article-title":"Tuberculosis","volume":"368","author":"Zumla","year":"2013","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"TNMI7-0036-2016","DOI":"10.1128\/microbiolspec.TNMI7-0036-2016","article-title":"Tuberculosis \u2013 a World Health Organization Perspective","volume":"5","author":"Sotgiu","year":"2017","journal-title":"Microbiol Spectr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis","volume":"31","author":"O\u2019Garra","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"S189","DOI":"10.1086\/429994","article-title":"Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis","volume":"41","author":"Algood","year":"2005","journal-title":"Clin Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/art.27271","article-title":"Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model","volume":"62","author":"Lin","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.4049\/jimmunol.175.2.1107","article-title":"Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses","volume":"175","author":"Lazarevic","year":"2005","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4049\/jimmunol.0903856","article-title":"Understanding latent tuberculosis: a moving target","volume":"185","author":"Lin","year":"2010","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.smim.2014.09.009","article-title":"The formation of the granuloma in tuberculosis infection","volume":"26","author":"Orme","year":"2014","journal-title":"Semin Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cell.2004.11.038","article-title":"Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages","volume":"119","author":"Gutierrez","year":"2004","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/cei.12170","article-title":"Alveolar macrophages in pulmonary host defence the unrecognized role of apoptosis as a mechanism of intracellular bacterial killing","volume":"174","author":"Aberdein","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/imr.12266","article-title":"Macrophage defense mechanisms against intracellular bacteria","volume":"264","author":"Weiss","year":"2015","journal-title":"Immunol Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1462-5822.2006.00705.x","article-title":"Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism","volume":"8","author":"Deretic","year":"2006","journal-title":"Cell Microbiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1001230","DOI":"10.1371\/journal.ppat.1001230","article-title":"Mycobacterium tuberculosis eis regulates autophagy, inflammation, and cell death through redox-dependent signaling","volume":"6","author":"Shin","year":"2010","journal-title":"PLoS Pathog"},{"key":"B18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri3259","article-title":"The immunological life cycle of tuberculosis","volume":"12","author":"Ernst","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.4049\/jimmunol.160.11.5448","article-title":"Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis","volume":"160","author":"Oddo","year":"1998","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1126\/science.1129577","article-title":"Human IRGM induces autophagy to eliminate intracellular mycobacteria","volume":"313","author":"Singh","year":"2006","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.4049\/jimmunol.0901274","article-title":"IFN-gamma expressed by T cells regulates the persistence of antigen presentation by limiting the survival of dendritic cells","volume":"183","author":"Russell","year":"2009","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.immuni.2009.08.025","article-title":"Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis","volume":"31","author":"Lin","year":"2009","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","first-page":"7474","DOI":"10.4049\/jimmunol.175.11.7474","article-title":"Coordinate expression of CC chemokine ligand 5, granulysin, and perforin in CD8+ T cells provides a host defense mechanism against Mycobacterium tuberculosis","volume":"175","author":"Stegelmann","year":"2005","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.cell.2011.12.023","article-title":"Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections","volume":"148","author":"Tobin","year":"2012","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2013.03.022","article-title":"TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species","volume":"153","author":"Roca","year":"2013","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1473-3099(15)70008-3","article-title":"Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study","volume":"15","author":"Ravimohan","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/joim.12256","article-title":"Inflammation and tuberculosis: host-directed therapies","volume":"277","author":"Zumla","year":"2015","journal-title":"J Intern Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri3813","article-title":"Advancing host-directed therapy for tuberculosis","volume":"15","author":"Wallis","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12916-016-0635-1","article-title":"Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis","volume":"14","author":"Zumla","year":"2016","journal-title":"BMC Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e17091","DOI":"10.1371\/journal.pone.0017091","article-title":"Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice","volume":"6","author":"Koo","year":"2011","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1089\/jir.2013.0123","article-title":"Etanercept exacerbates inflammation and pathology in a rabbit model of active pulmonary tuberculosis","volume":"34","author":"Tsenova","year":"2014","journal-title":"J Interferon Cytokine Res"},{"key":"B33","first-page":"124","article-title":"Tumor necrosis factor neutralization combined with chemotherapy enhances Mycobacterium tuberculosis clearance and reduces lung pathology","volume":"2","author":"Bourigault","year":"2013","journal-title":"Am J Clin Exp Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature13967","article-title":"Interception of host angiogenic signalling limits mycobacterial growth","volume":"517","author":"Oehlers","year":"2015","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1073\/pnas.1424563112","article-title":"Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery","volume":"112","author":"Datta","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.4049\/jimmunol.179.4.2060","article-title":"Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin","volume":"179","author":"Liu","year":"2007","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e5810","DOI":"10.1371\/journal.pone.0005810","article-title":"Convergence of IL-1beta and VDR activation pathways in human TLR2\/1-induced antimicrobial responses","volume":"4","author":"Liu","year":"2009","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.chom.2009.08.004","article-title":"Vitamin D3 induces autophagy in human monocytes\/macrophages via cathelicidin","volume":"6","author":"Yuk","year":"2009","journal-title":"Cell Host Microbe"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1003407","DOI":"10.1371\/journal.ppat.1003407","article-title":"Vitamin D induces interleukin-1beta expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection","volume":"9","author":"Verway","year":"2013","journal-title":"PLoS Pathog"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1002689","DOI":"10.1371\/journal.ppat.1002689","article-title":"Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy","volume":"8","author":"Campbell","year":"2012","journal-title":"PLoS Pathog"},{"key":"B41","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1365-2567.2008.03024.x","article-title":"1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection","volume":"127","author":"Coussens","year":"2009","journal-title":"Immunology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"15449","DOI":"10.1073\/pnas.1200072109","article-title":"Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment","volume":"109","author":"Coussens","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/sji.12006","article-title":"1,25-dihydroxyvitamin D3 inhibits nuclear factor kappa B activation by stabilizing inhibitor IkappaBalpha via mRNA stability and reduced phosphorylation in passively sensitized human airway smooth muscle cells","volume":"77","author":"Song","year":"2013","journal-title":"Scand J Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2220\/biomedres.27.1","article-title":"Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity","volume":"27","author":"Imazeki","year":"2006","journal-title":"Biomed Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.4049\/jimmunol.0803217","article-title":"1,25-dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3","volume":"183","author":"Jeffery","year":"2009","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4049\/jimmunol.1000695","article-title":"The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation","volume":"186","author":"Baeke","year":"2011","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.intimp.2016.02.021","article-title":"Effect of vitamin D3 on chemokine levels and regulatory T-cells in pulmonary tuberculosis","volume":"34","author":"Harishankar","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1189\/jlb.1013549","article-title":"Vitamin D(3) and phenylbutyrate promote development of a human dendritic cell subset displaying enhanced antimicrobial properties","volume":"95","author":"van der Does","year":"2014","journal-title":"J Leukoc Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e1005007","DOI":"10.1371\/journal.ppat.1005007","article-title":"Phenylbutyrate is bacteriostatic against Mycobacterium tuberculosis and regulates the macrophage response to infection, synergistically with 25-hydroxy-vitamin D3","volume":"11","author":"Coussens","year":"2015","journal-title":"PLoS Pathog"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1080\/15548627.2015.1075110","article-title":"Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in human macrophages","volume":"11","author":"Rekha","year":"2015","journal-title":"Autophagy"},{"key":"B51","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1111\/j.1742-4658.2009.07332.x","article-title":"Apoptosis and autophagy: targeting autophagy signalling in cancer cells -\u2018trick or treats\u2019?","volume":"276","author":"Corcelle","year":"2009","journal-title":"FEBS J"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1003946","DOI":"10.1371\/journal.ppat.1003946","article-title":"Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth","volume":"10","author":"Stanley","year":"2014","journal-title":"PLoS Pathog"},{"key":"B53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.15252\/emmm.201404137","article-title":"Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion","volume":"7","author":"Schiebler","year":"2015","journal-title":"EMBO Mol Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.coph.2013.06.007","article-title":"TB: the Yin and Yang of lipid mediators","volume":"13","author":"Tobin","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.4049\/jimmunol.0900477","article-title":"Effects of low-dose aspirin on acute inflammatory responses in humans","volume":"183","author":"Morris","year":"2009","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/infdis\/jit152","article-title":"Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis","volume":"208","author":"Vilaplana","year":"2013","journal-title":"J Infect Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature13489","article-title":"Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk","volume":"511","author":"Mayer-Barber","year":"2014","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"385","author":"Blum","year":"2015","journal-title":"Lancet"},{"key":"B59","first-page":"47","article-title":"Prednisolone: a beneficial and safe adjunct to antituberculosis treatment? A randomized controlled trial","volume":"3","author":"Bilaceroglu","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ebiom.2016.01.015","article-title":"Adjunctive phosphodiesterase-4 inhibitor therapy improves antibiotic response to pulmonary tuberculosis in a rabbit model","volume":"4","author":"Subbian","year":"2016","journal-title":"EBioMedicine"},{"key":"B61","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/infdis\/jit187","article-title":"Adjuvant host-directed therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatment","volume":"208","author":"Maiga","year":"2013","journal-title":"J Infect Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1164\/rccm.201110-1769OC","article-title":"Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases","volume":"185","author":"Walker","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/iep.12191","article-title":"Adjunctive role of MMP-9 inhibition along with conventional anti-tubercular drugs against experimental tuberculous meningitis","volume":"97","author":"Majeed","year":"2016","journal-title":"Int J Exp Pathol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"B65","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/infdis\/jit550","article-title":"Statin therapy reduces the Mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation","volume":"209","author":"Parihar","year":"2014","journal-title":"J Infect Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1093\/jac\/dku166","article-title":"Simvastatin increases the in vivo activity of the first-line tuberculosis regimen","volume":"69","author":"Skerry","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.cmet.2014.04.002","article-title":"Pharmacological inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle","volume":"19","author":"Pirinen","year":"2014","journal-title":"Cell Metab"},{"key":"B68","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ab.2010.04.040","article-title":"A high-throughput respirometric assay for mitochondrial biogenesis and toxicity","volume":"404","author":"Beeson","year":"2010","journal-title":"Anal Biochem"},{"key":"B69","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.nutres.2013.07.016","article-title":"Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity","volume":"33","author":"Wang","year":"2013","journal-title":"Nutr Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1172\/JCI73639","article-title":"PD-1 identifies the patient-specific CD8(+) tumor-reactive repertoire infiltrating human tumors","volume":"124","author":"Gros","year":"2014","journal-title":"J Clin Invest"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.drudis.2015.07.003","article-title":"Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies","volume":"20","author":"Borch","year":"2015","journal-title":"Drug Discov Today"},{"key":"B72","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S2213-2600(13)70234-0","article-title":"Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial","volume":"2","author":"Skrahin","year":"2014","journal-title":"Lancet Respir Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00005-015-0347-9","article-title":"Mesenchymal stromal cell therapy in MDR\/XDR tuberculosis: a concise review","volume":"63","author":"Joshi","year":"2015","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e58309","DOI":"10.1371\/journal.pone.0058309","article-title":"A broad profile of co-dominant epitopes shapes the peripheral Mycobacterium tuberculosis specific CD8+ T-cell immune response in South African patients with active tuberculosis","volume":"8","author":"Axelsson-Robertson","year":"2013","journal-title":"PLoS One"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e6984","DOI":"10.1371\/journal.pone.0006984","article-title":"Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis","volume":"4","author":"Dawson","year":"2009","journal-title":"PLoS One"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.molimm.2009.11.005","article-title":"Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis","volume":"47","author":"Encinales","year":"2010","journal-title":"Mol Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.4049\/jimmunol.1003189","article-title":"A novel human IgA monoclonal antibody protects against tuberculosis","volume":"186","author":"Balu","year":"2011","journal-title":"J Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1128\/IAI.01011-07","article-title":"Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs","volume":"76","author":"Chakravarty","year":"2008","journal-title":"Infect Immun"},{"key":"B79","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1146\/annurev.micro.57.030502.091033","article-title":"The secret lives of the pathogenic mycobacteria","volume":"57","author":"Cosma","year":"2003","journal-title":"Annu Rev Microbiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3389\/fimmu.2012.00411","article-title":"The granuloma in tuberculosis: dynamics of a host-pathogen collusion","volume":"3","author":"Ehlers","year":"2012","journal-title":"Front Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/00002030-200401230-00015","article-title":"A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis","volume":"18","author":"Wallis","year":"2004","journal-title":"AIDS"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e0146318","DOI":"10.1371\/journal.pone.0146318","article-title":"Circulating angiogenic factors as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis","volume":"11","author":"Kumar","year":"2016","journal-title":"PLoS One"},{"key":"B83","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5588\/ijtld.16.0565","article-title":"Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis","volume":"21","author":"Kumar","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1586\/ecp.11.41","article-title":"Immunomodulation by vitamin D: implications for TB","volume":"4","author":"Chun","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fmicb.2011.00067","article-title":"A novel in vitro human macrophage model to study the persistence of Mycobacterium tuberculosis using vitamin D(3) and retinoic acid activated THP-1 macrophages","volume":"2","author":"Estrella","year":"2011","journal-title":"Front Microbiol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1172\/JCI31097","article-title":"Neutrophil-mediated innate immune resistance to mycobacteria","volume":"117","author":"Martineau","year":"2007","journal-title":"J Clin Invest"},{"key":"B87","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pep.2013.02.007","article-title":"Bacterial expression and antibiotic activities of recombinant variants of human beta-defensins on pathogenic bacteria and M. tuberculosis","volume":"89","author":"Corrales-Garcia","year":"2013","journal-title":"Protein Expr Purif"},{"key":"B88","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijantimicag.2012.09.015","article-title":"Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis","volume":"41","author":"Rivas-Santiago","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"B89","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1681\/ASN.2013040355","article-title":"Suppression of iron-regulatory hepcidin by vitamin D","volume":"25","author":"Bacchetta","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4049\/jimmunol.1400736","article-title":"Cutting edge: vitamin D regulates lipid metabolism in Mycobacterium tuberculosis infection","volume":"193","author":"Salamon","year":"2014","journal-title":"J Immunol"},{"key":"B91","first-page":"3","article-title":"The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion","volume":"38","author":"Nursyam","year":"2006","journal-title":"Acta Med Indones"},{"key":"B92","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1164\/rccm.200804-567OC","article-title":"Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial","volume":"179","author":"Wejse","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(10)61889-2","article-title":"High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial","volume":"377","author":"Martineau","year":"2011","journal-title":"Lancet"},{"key":"B94","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2466-13-23","article-title":"Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis","volume":"13","author":"Mily","year":"2013","journal-title":"BMC Pulm Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0065-230X(04)91004-4","article-title":"Histone deacetylase inhibitors","volume":"91","author":"Marks","year":"2004","journal-title":"Adv Cancer Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1128\/AAC.00818-09","article-title":"Phenylbutyrate induces antimicrobial peptide expression","volume":"53","author":"Steinmann","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e0138340","DOI":"10.1371\/journal.pone.0138340","article-title":"Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial","volume":"10","author":"Mily","year":"2015","journal-title":"PLoS One"},{"key":"B98","doi-asserted-by":"publisher","first-page":"18890","DOI":"10.1074\/jbc.M110.206110","article-title":"Hormonally active vitamin D3 (1alpha,25-dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection","volume":"286","author":"Campbell","year":"2011","journal-title":"J Biol Chem"},{"key":"B99","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2334-13-22","article-title":"Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis\u2019","volume":"13","author":"Salahuddin","year":"2013","journal-title":"BMC Infect Dis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3945\/ajcn.115.113886","article-title":"High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial","volume":"102","author":"Tukvadze","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"B101","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1086\/427995","article-title":"Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda","volume":"191","author":"Mayanja-Kizza","year":"2005","journal-title":"J Infect Dis"},{"key":"B102","doi-asserted-by":"publisher","first-page":"ofu020","DOI":"10.1093\/ofid\/ofu020","article-title":"Corticosteroid effects on sputum culture in pulmonary tuberculosis: a meta-regression analysis","volume":"1","author":"Wallis","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1056\/NEJMoa040573","article-title":"Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults","volume":"351","author":"Thwaites","year":"2004","journal-title":"N Engl J Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(96)12273-X","article-title":"Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol","volume":"349","author":"Condos","year":"1997","journal-title":"Lancet"},{"key":"B105","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3346\/jkms.2004.19.2.167","article-title":"Six-month therapy with aerosolized interferon-gamma for refractory multidrug-resistant pulmonary tuberculosis","volume":"19","author":"Koh","year":"2004","journal-title":"J Korean Med Sci"},{"key":"B106","first-page":"99","article-title":"Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis","volume":"11","author":"Giosue","year":"2000","journal-title":"Eur Cytokine Netw"},{"key":"B107","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1164\/rccm.200211-1359OC","article-title":"Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis","volume":"168","author":"Johnson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"584","DOI":"10.5114\/aoms.2015.52362","article-title":"The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis","volume":"11","author":"Shen","year":"2015","journal-title":"Arch Med Sci"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1096\/fj.01-0433rev","article-title":"Vitamin D: its role and uses in immunology","volume":"15","author":"Deluca","year":"2001","journal-title":"FASEB J"},{"key":"B110","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cyto.2007.08.005","article-title":"1, 25 dihydroxyvitamin D3 modulated cytokine response in pulmonary tuberculosis","volume":"40","author":"Vidyarani","year":"2007","journal-title":"Cytokine"},{"key":"B111","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cyto.2012.06.238","article-title":"Effect of vitamin D3 on chemokine expression in pulmonary tuberculosis","volume":"60","author":"Selvaraj","year":"2012","journal-title":"Cytokine"},{"key":"B112","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.intimp.2014.08.021","article-title":"1,25-dihydroxy vitamin D3 downregulates pro-inflammatory cytokine response in pulmonary tuberculosis","volume":"23","author":"Harishankar","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1023\/B:JOCI.0000025446.44146.52","article-title":"Effect of vitamin D3 on phagocytic potential of macrophages with live Mycobacterium tuberculosis and lymphoproliferative response in pulmonary tuberculosis","volume":"24","author":"Chandra","year":"2004","journal-title":"J Clin Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1349-7006.2006.00144.x","article-title":"1alpha,25-Dihydroxyvitamin D3 downmodulates the functional differentiation of Th1 cytokine-conditioned bone marrow-derived dendritic cells beneficial for cytotoxic T lymphocyte generation","volume":"97","author":"Matsuzaki","year":"2006","journal-title":"Cancer Sci"},{"key":"B115","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cyto.2008.11.004","article-title":"Effect of 1,25 dihydroxyvitamin D3 on intracellular IFN-gamma and TNF-alpha positive T cell subsets in pulmonary tuberculosis","volume":"45","author":"Prabhu Anand","year":"2009","journal-title":"Cytokine"},{"key":"B116","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4049\/jimmunol.178.1.145","article-title":"1,25-dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells","volume":"178","author":"Penna","year":"2007","journal-title":"J Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1017\/S0007114510002333","article-title":"Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland","volume":"104","author":"Nielsen","year":"2010","journal-title":"Br J Nutr"},{"key":"B118","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1089\/dna.2014.2745","article-title":"Autophagy in the fight against tuberculosis","volume":"34","author":"Bento","year":"2015","journal-title":"DNA Cell Biol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/2049-632X.12023","article-title":"Autophagy as an innate defense against mycobacteria","volume":"67","author":"Jo","year":"2013","journal-title":"Pathog Dis"},{"key":"B120","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cell.2012.06.040","article-title":"Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway","volume":"150","author":"Watson","year":"2012","journal-title":"Cell"},{"key":"B121","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat Genet"},{"key":"B122","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev.immunol.021908.132537","article-title":"Enhancing immunity through autophagy","volume":"27","author":"Munz","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"903680","DOI":"10.1155\/2014\/903680","article-title":"Anti-inflammatory and antimicrobial actions of vitamin D in combating TB\/HIV","volume":"2014","author":"Coussens","year":"2014","journal-title":"Scientifica (Cairo)"},{"key":"B124","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.tips.2012.05.003","article-title":"NSAIDs: eNdocannabinoid stimulating anti-inflammatory drugs?","volume":"33","author":"Fowler","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"B125","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1186\/s12879-016-1938-8","article-title":"The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection","volume":"16","author":"Tonby","year":"2016","journal-title":"BMC Infect Dis"},{"key":"B126","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation","volume":"16","author":"Basil","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1742-1241.2007.01320.x","article-title":"Zileuton: clinical implications of 5-lipoxygenase inhibition in severe airway disease","volume":"61","author":"Berger","year":"2007","journal-title":"Int J Clin Pract"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1128\/CVI.00423-12","article-title":"Dexamethasone downregulates the systemic cytokine response in patients with community-acquired pneumonia","volume":"19","author":"Remmelts","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"B129","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5005\/ijcdas-52-3-153","article-title":"Role of corticosteroids in the treatment of tuberculosis: an evidence-based update","volume":"52","author":"Kadhiravan","year":"2010","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"B130","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1473-3099(12)70321-3","article-title":"Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis","volume":"13","author":"Critchley","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"B131","doi-asserted-by":"publisher","first-page":"CD002244","DOI":"10.1002\/14651858.CD002244.pub3","article-title":"Corticosteroids for managing tuberculous meningitis","volume":"1","author":"Prasad","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"B132","doi-asserted-by":"publisher","first-page":"CD000526","DOI":"10.1002\/14651858.CD000526","article-title":"Interventions for treating tuberculous pericarditis","volume":"4","author":"Mayosi","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"B133","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0041-3879(83)90032-6","article-title":"Study of chemotherapy regimens of 5 and 7 months\u2019 duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India","volume":"64","year":"1983","journal-title":"Tubercle"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1378\/chest.107.6.1621","article-title":"Prednisone as adjunctive therapy in the management of pulmonary tuberculosis. Report of 12 cases and review of the literature","volume":"107","author":"Muthuswamy","year":"1995","journal-title":"Chest"},{"key":"B135","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e1002262","DOI":"10.1371\/journal.ppat.1002262","article-title":"Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs","volume":"7","author":"Subbian","year":"2011","journal-title":"PLoS Pathog"},{"key":"B137","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ajpath.2011.03.039","article-title":"Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology","volume":"179","author":"Subbian","year":"2011","journal-title":"Am J Pathol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e30749","DOI":"10.1371\/journal.pone.0030749","article-title":"Successful shortening of tuberculosis treatment using adjuvant host-directed therapy with FDA-approved phosphodiesterase inhibitors in the mouse model","volume":"7","author":"Maiga","year":"2012","journal-title":"PLoS One"},{"key":"B139","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1183\/09031936.00015411","article-title":"Matrix metalloproteinases in tuberculosis","volume":"38","author":"Elkington","year":"2011","journal-title":"Eur Respir J"},{"key":"B140","doi-asserted-by":"publisher","first-page":"71s76","DOI":"10.1126\/scitranslmed.3001847","article-title":"Tuberculosis immunopathology: the neglected role of extracellular matrix destruction","volume":"3","author":"Elkington","year":"2011","journal-title":"Sci Transl Med"},{"key":"B141","doi-asserted-by":"publisher","first-page":"e1004917","DOI":"10.1371\/journal.ppat.1004917","article-title":"Neutrophil-derived MMP-8 drives AMPK-dependent matrix destruction in human pulmonary tuberculosis","volume":"11","author":"Ong","year":"2015","journal-title":"PLoS Pathog"},{"key":"B142","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2296-4-18","article-title":"Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials","volume":"4","author":"Edwards","year":"2003","journal-title":"BMC Fam Pract"},{"key":"B144","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1465-9921-6-82","article-title":"The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia","volume":"6","author":"Mortensen","year":"2005","journal-title":"Respir Res"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1097\/01.CCM.0000207345.92928.E4","article-title":"Statin use and mortality within 180 days after bacteremia: a population-based cohort study","volume":"34","author":"Thomsen","year":"2006","journal-title":"Crit Care Med"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat Med"},{"key":"B147","doi-asserted-by":"publisher","first-page":"717","DOI":"10.5588\/ijtld.13.0854","article-title":"The effects of statin use on the development of tuberculosis among patients with diabetes mellitus","volume":"18","author":"Kang","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"B148","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/thoraxjnl-2015-207052","article-title":"Statin treatment is associated with a decreased risk of active tuberculosis: an analysis of a nationally representative cohort","volume":"71","author":"Lai","year":"2016","journal-title":"Thorax"},{"key":"B149","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","article-title":"Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development","volume":"36","author":"van der Windt","year":"2012","journal-title":"Immunity"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1124\/mol.107.038984","article-title":"Resveratrol (trans-3,5,4\u2019-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor","volume":"72","author":"Singh","year":"2007","journal-title":"Mol Pharmacol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"e83139","DOI":"10.1371\/journal.pone.0083139","article-title":"Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells","volume":"8","author":"Dilek","year":"2013","journal-title":"PLoS One"},{"key":"B152","doi-asserted-by":"publisher","first-page":"851387","DOI":"10.1155\/2015\/851387","article-title":"Novel approaches to treatment of advanced melanoma: a review on targeted therapy and immunotherapy","volume":"2015","author":"Niezgoda","year":"2015","journal-title":"Biomed Res Int"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/cas.12986","article-title":"Lymphocyte-activation gene-3, an important immune checkpoint in cancer","volume":"107","author":"He","year":"2016","journal-title":"Cancer Sci"},{"key":"B154","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.ajpath.2014.11.003","article-title":"LAG3 expression in active Mycobacterium tuberculosis infections","volume":"185","author":"Phillips","year":"2015","journal-title":"Am J Pathol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12026-007-0059-2","article-title":"Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants","volume":"38","author":"O\u2019Reilly","year":"2007","journal-title":"Immunol Res"},{"key":"B156","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.coi.2010.01.020","article-title":"Adoptive T cell therapy of cancer","volume":"22","author":"Brenner","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijid.2015.01.016","article-title":"Cellular therapy in tuberculosis","volume":"32","author":"Parida","year":"2015","journal-title":"Int J Infect Dis"},{"key":"B158","doi-asserted-by":"publisher","first-page":"S217","DOI":"10.1093\/cid\/civ615","article-title":"T-cell therapy: options for infectious diseases","volume":"61","author":"Parida","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B159","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"B160","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1089\/jir.2006.0103","article-title":"IFN-gamma therapy of tuberculosis and related infections","volume":"27","author":"Reljic","year":"2007","journal-title":"J Interferon Cytokine Res"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1128\/CVI.05013-11","article-title":"Clinical significance of interleukin-2\/gamma interferon ratios in Mycobacterium tuberculosis-specific T-cell signatures","volume":"18","author":"Suter-Riniker","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.tube.2016.08.001","article-title":"Antibodies and tuberculosis","volume":"101","author":"Jacobs","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"B163","doi-asserted-by":"publisher","first-page":"e1003472","DOI":"10.1371\/journal.ppat.1003472","article-title":"B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response","volume":"9","author":"Kozakiewicz","year":"2013","journal-title":"PLoS Pathog"},{"key":"B164","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.4049\/jimmunol.180.5.3329","article-title":"Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection","volume":"180","author":"Maglione","year":"2008","journal-title":"J Immunol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nri3582","article-title":"The function of Fcgamma receptors in dendritic cells and macrophages","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.1128\/IAI.73.10.6711-6720.2005","article-title":"Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies","volume":"73","author":"de Valliere","year":"2005","journal-title":"Infect Immun"},{"key":"B167","doi-asserted-by":"publisher","first-page":"150171","DOI":"10.1098\/rsob.150171","article-title":"Naturally produced opsonizing antibodies restrict the survival of Mycobacterium tuberculosis in human macrophages by augmenting phagosome maturation","volume":"5","author":"Kumar","year":"2015","journal-title":"Open Biol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.tube.2009.02.003","article-title":"Prophylactic effect of administration of human gamma globulins in a mouse model of tuberculosis","volume":"89","author":"Olivares","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"key":"B169","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.chom.2013.02.009","article-title":"Antibody-mediated immunity against tuberculosis: implications for vaccine development","volume":"13","author":"Achkar","year":"2013","journal-title":"Cell Host Microbe"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00171\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T04:02:46Z","timestamp":1693108966000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00171\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,18]]},"references-count":169,"alternative-id":["10.3389\/fmed.2017.00171"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2017.00171","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,18]]},"article-number":"171"}}